Vietnamese Company Issued FDA Warning Over Histamine In Yellowfin

The US Food and Drug Administration (FDA) recently sent a warning letter to Vietnamese-based tuna processor Golden Shrimp Seafood Joint Stock Company for selling “adulterated” yellowfin products. The FDA inspected the company’s processing facility in the Phu Yen province in December last year during which they found serious Hazard Analysis and Critical Control Point (HACCP) violations involving histamine. The agency said in a statement that the investigation was carried out after a consumer complained of histamine from “saku, cubed, and ground yellowfin product.”

The FDA stated: “Your frozen histamine-forming seafood yellowfin tuna products are adulterated in that they have been prepared, packed, or held under conditions whereby they may have been rendered injurious to health”. The FDA sends warnings to entities under its jurisdiction as part of its enforcement activities. Some letters are not posted for public view until weeks or months after they are issued. Business owners will have 15 days to respond to FDA warnings to explain how they will address the issues that have been raised.